SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001318641-19-000025
Filing Date
2019-08-14
Accepted
2019-08-14 08:45:58
Documents
49
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbli-063019x10q.htm 10-Q 744458
2 EXHIBIT 31.1 cbli-063019xex311.htm EX-31.1 13326
3 EXHIBIT 32.1 cbli-063019xex321.htm EX-32.1 8078
  Complete submission text file 0001318641-19-000025.txt   3835435

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cbli-20190630.xml EX-101.INS 707493
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cbli-20190630.xsd EX-101.SCH 31334
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cbli-20190630_cal.xml EX-101.CAL 46759
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cbli-20190630_def.xml EX-101.DEF 166644
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cbli-20190630_lab.xml EX-101.LAB 469165
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cbli-20190630_pre.xml EX-101.PRE 272403
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32954 | Film No.: 191023049
SIC: 8731 Services-Commercial Physical & Biological Research